Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players (GIRDH)

Evaluation of the Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players Occurring Over One Training Season

The main objective of this study is to estimate the incidence and prevalence of Internal Rotation Deficit (IRD) defined by a measure of IRD 2 (Internal Rotation Deficit in position 2) strictly greater than 20 ° in a population of advanced-level handball players over a training season.

Study Overview

Detailed Description

The secondary objectives of this study are :

A- To estimate and compare the prevalence of Internal Rotation Deficit within groups

B- To assess the association between the Internal Rotation Deficit and the appearance of a shoulder pain and/or discomfort when throwing

C- To assess the association between Internal Rotation Deficit and the appearance of a shoulder pathology demonstrated by clinical examination by at least one abnormality in one of the following three tests: the arming apprehension test, the relocation test or the O'Brien test

D- Assess changes in values of IRD 2, the ratio IRD 2/GRE 2, and the Total Range of Motion over the training season

E- Evaluate the association between the values of IRD 2 and the appearance of shoulder pain or discomfort when throwing

F- To evaluate the association between IRD 2 values and the appearance of a shoulder pathology (at least one anomaly in one of three tests: the arming apprehension test, the relocation test or the O'Brien test).

G- To assess the association between values of the IRD 2/GRE 2 ratio and the appearance of shoulder pain or discomfort when throwing

H- To assess the association between values of the IRD 2/GRE 2 ratio and the appearance of a shoulder pathology (at least one anomaly in one of three tests: the arming apprehension test, the relocation test or the O'Brien test).

I- To estimate the optimal threshold value of the IRD 2/GRE 2 ratio that would define an Internal Rotation Deficit in a more relevant fashion as compred to the IRD 2 alone

Study Type

Observational

Enrollment (Actual)

86

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nîmes Cedex 9, France, 30029
        • CHRU de Nîmes - Hôpital Universitaire Carémeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population is composed of all members of the professional and pre-professional handball clubs in the city of Nîmes, France (the USAM and HBCN clubs). Younger players who are members of the training centers associated with these same clubs will also be included.

Description

Inclusion Criteria:

  • The subject or his/her legal guardian must have given his/her informed and signed consent
  • The subject must be insured or beneficiary of a health insurance plan
  • The subject is a member of the professional and pre-professional handball clubs in Nîmes, France (the USAM or HBCN clubs) -- OR-- a member of the training centers associated with the same clubs whose parents or legal representatives have given informed consent

Exclusion Criteria:

  • The subject is under judicial protection, under tutorship or curatorship
  • The subject or his/her legal respresentative refuses to sign the consent
  • It is impossible to correctly inform the subject
  • The subject is pregnant, parturient, or breastfeeding
  • The subject has been operated for shoulder instability, regardless of the surgical technique used
  • The subject has a history of fracture of the proximal end of the humerus and / or elbow
  • The subject has a history of rotator cuff surgery
  • The subject has neurological or spinal problems, or has received physiotherapy on the shoulder complex within 30 days prior to the study assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Professional players, men
This group includes professional, male, handball players meeting study inclusion criteria.
Professional players, women
This group includes professional, female, handball players meeting study inclusion criteria.
Junior players, men
This group includes junior, male, handball players meeting study inclusion criteria.
Junior players, women
This group includes junior, female, handball players meeting study inclusion criteria.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence/absence of an internal rotation deficit (IRD 2 > 20°)
Time Frame: 6 months
IRD 2 = internal rotation deficit in position 2 Position 2 = dominant arm in abduction at 90°
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence/absence of an internal rotation deficit (IRD 2 > 20°)
Time Frame: baseline (Day 0)
baseline (Day 0)
Presence/absence of an internal rotation deficit (IRD 2 > 20°)
Time Frame: 3 months
3 months
Measure of the internal rotation deficit
Time Frame: baseline (day 0)
baseline (day 0)
Measure of the internal rotation deficit
Time Frame: 3 months
3 months
Measure of the internal rotation deficit
Time Frame: 6 months
6 months
The ratio of DRI 2 / GRE 2
Time Frame: baseline (day 0)
GRE 2 = measure of the external gain in rotation in position 2 Position 2 = dominant arm in abduction at 90°
baseline (day 0)
The ratio of DRI 2 / GRE 2
Time Frame: 3 months
3 months
The ratio of DRI 2 / GRE 2
Time Frame: 6 months
6 months
Measure of the total range of motion
Time Frame: baseline (day 0)
baseline (day 0)
Measure of the total range of motion
Time Frame: 3 months
3 months
Measure of the total range of motion
Time Frame: 6 months
6 months
Presence/absence of pain when throwing (yes/no)
Time Frame: baseline (day 0)
baseline (day 0)
Presence/absence of pain when throwing (yes/no)
Time Frame: 3 months
3 months
Presence/absence of pain when throwing (yes/no)
Time Frame: 6 months
6 months
Presence of discomfort when throwing (visual analog scale from 0 to 100)
Time Frame: baseline (day 0)
baseline (day 0)
Presence of discomfort when throwing (visual analog scale from 0 to 100)
Time Frame: 3 months
3 months
Presence of discomfort when throwing (visual analog scale from 0 to 100)
Time Frame: 6 months
6 months
Presence/absence of shoulder pathology
Time Frame: baseline (day 0)
baseline (day 0)
Presence/absence of shoulder pathology
Time Frame: 3 months
3 months
Presence/absence of shoulder pathology
Time Frame: 6 months
6 months
Shoulder clinical exam: the arming apprehension test
Time Frame: baseline (day 0)
baseline (day 0)
Shoulder clinical exam: the arming apprehension test
Time Frame: 3 months
3 months
Shoulder clinical exam: the arming apprehension test
Time Frame: 6 months
6 months
Shoulder clinical exam: relocation test
Time Frame: baseline (day 0)
baseline (day 0)
Shoulder clinical exam: relocation test
Time Frame: 3 months
3 months
Shoulder clinical exam: relocation test
Time Frame: 6 months
6 months
Shoulder clinical exam: the O'Brien test
Time Frame: baseline (day 0)
baseline (day 0)
Shoulder clinical exam: the O'Brien test
Time Frame: 3 months
3 months
Shoulder clinical exam: the O'Brien test
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

August 1, 2014

Study Registration Dates

First Submitted

December 9, 2013

First Submitted That Met QC Criteria

December 10, 2013

First Posted (Estimate)

December 13, 2013

Study Record Updates

Last Update Posted (Estimate)

March 26, 2015

Last Update Submitted That Met QC Criteria

March 25, 2015

Last Verified

March 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Athletic Injuries

3
Subscribe